Here are relevant reports on : in-vitro-diagnostics-ivd-market
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030
The global assisted reproductive technology market, valued at US$4.02 billion in 2024, stood at US$4.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$6.02 billion by the end of the period. The Asia Pacific region is expected to grow at the highest CAGR of 7.9% during the forecast period owing to the increasing infertility rates, rising awareness of fertility treatments, and improving healthcare infrastructure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020
The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, at a CAGR of 11.7%. Protein labeling is carried out using labeling reagents and kits to label an antibody or other protein, to make a fluorescent probe, enzyme conjugate, biotinylated binding reagent, or iodine-labeled tracer for detecting proteins in tissues, cells, and biochemical assays.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Nanorobotics Market by Type (Nano-manipulator, Nanorobotic System), Deployment (In-vivo, In-vitro/Ex-vivo, Others), Technology (Magnetic Actuation, Biohybrid/Biological Propulsion, Acoustic/Ultrasound Propulsion, Others)-Global Forecast to 2032
The global nanorobotics market is projected to grow from USD 2.27 billion in 2025 to USD 4.52 billion by 2032, expanding at a CAGR of 10.6% during the forecast period. The Key companies operating in the nanorobotics market include Bruker (Germany), Thermo Fisher Scientific Inc. (US), Hitachi High-Tech Corporation (Japan), JEOL LTD. (Japan), ZEISS Group (Germany), Oxford Instruments (UK), CIQTEK Co., Ltd (China).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Device Technologies Market Size, Share & Trends by Type (In Vitro Diagnostics, Diagnostics Imaging, Orthopedic, Ophthalmology, Cardiology, Endoscopy, Diabetes Care, Respiratory Care & Anesthesia, Kidney/Dialysis Devices) and Region - Global Forecast to 2027
The global Top 10 Medical Device Technologies market, valued at US$417.7 billion in 2021, stood at US$437.4 billion in 2022 and is projected to advance at a resilient CAGR of 5.7% from 2022 to 2027, culminating in a forecasted valuation of US$577.5 billion by the end of the period. This growth is driven by trends such as the shift from centralized to point-of-care testing, increasing chronic disease prevalence due to urbanization and lifestyle changes, and growing healthcare needs in emerging economies like India, China, and Brazil.
- Published: May 2023
- Price: $ 8150
- TOC Available:
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market - 2019 By Types, Application & Geography
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (MRI, CT, X-ray, Ultrasound), Applications (IVD, Radiology, Cardiology, Neurology, Obstetrics/GYN), End User (Hospitals, Imaging Centers, Diagnostic Labs) & Region - Global Forecast to 2029
The global AI in medical diagnostics market, valued at US$1.33 billion in 2023, stood at US$1.71 billion in 2024 and is projected to advance at a resilient CAGR of 22.5% from 2024 to 2029, culminating in a forecasted valuation of US$4.72 billion by the end of the period. Growth in the AI in medical diagnostics market is primarily driven by the growing demand for AI tools, increasing focus on reducing the workload of radiologists, influx of large & complex datasets, funding for AI-based startups, and growing cross-industry partnerships & collaborations.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
